VANGUARD GROUP INC - X4 PHARMACEUTICALS INC ownership

X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 55 filers reported holding X4 PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of X4 PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$8,528,941
-43.5%
7,824,717
+0.5%
0.00%
Q2 2023$15,107,052
+299.7%
7,787,140
+79.2%
0.00%
Q1 2023$3,779,551
+6.3%
4,344,311
+21.3%
0.00%
Q4 2022$3,555,326
-35.2%
3,580,389
+11.6%
0.00%
Q3 2022$5,486,000
+695.1%
3,208,103
+348.6%
0.00%
Q2 2022$690,000
-39.7%
715,175
+9.5%
0.00%
Q1 2022$1,144,000
-46.5%
653,185
-30.0%
0.00%
Q4 2021$2,137,000
-56.8%
933,240
-0.1%
0.00%
Q3 2021$4,942,000
-15.3%
934,352
+4.1%
0.00%
Q2 2021$5,834,000
-8.0%
897,641
+21.9%
0.00%
Q1 2021$6,343,000
+34.2%
736,602
+0.2%
0.00%
Q4 2020$4,726,000
-2.7%
734,966
+2.4%
0.00%
Q3 2020$4,857,000
-27.7%
717,392
-0.4%
0.00%
Q2 2020$6,716,000
-9.1%
720,625
-2.5%
0.00%
Q1 2020$7,391,000
-4.1%
739,048
+2.5%
0.00%
Q4 2019$7,711,000
+11.9%
720,686
+33.0%
0.00%
Q3 2019$6,888,000
-12.2%
541,925
+3.7%
0.00%
Q2 2019$7,842,000
+422.1%
522,811
+506.0%
0.00%
Q1 2019$1,502,00086,2720.00%
Other shareholders
X4 PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Tri Locum Partners LP 6,247,500$6,809,7752.18%
Bain Capital Life Sciences Investors, LLC 15,960,588$17,397,0411.94%
Stonepine Capital Management, LLC 5,273,685$5,748,3171.91%
NEA Management Company, LLC 14,986,793$16,335,6041.26%
Sio Capital Management, LLC 2,599,003$2,832,9130.88%
New Leaf Venture Partners, L.L.C. 335,000$365,1500.47%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,973,683$2,151,3140.25%
Monashee Investment Management LLC 427,265$465,7190.20%
Orbimed Advisors 7,133,515$7,775,5310.16%
Parkman Healthcare Partners LLC 800,000$872,0000.16%
View complete list of X4 PHARMACEUTICALS INC shareholders